180 related articles for article (PubMed ID: 15950136)
21. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease.
Llor C; Moragas A; Hernández S; Bayona C; Miravitlles M
Am J Respir Crit Care Med; 2012 Oct; 186(8):716-23. PubMed ID: 22923662
[TBL] [Abstract][Full Text] [Related]
22. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
23. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
Solèr M; Mütterlein R; Cozma G;
Respiration; 2007; 74(1):26-32. PubMed ID: 16772707
[TBL] [Abstract][Full Text] [Related]
24. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
25. Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD.
Anzueto A; Miravitlles M
Respir Med; 2010 Oct; 104(10):1396-403. PubMed ID: 20580215
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
[TBL] [Abstract][Full Text] [Related]
27. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
Siempos II; Dimopoulos G; Korbila IP; Manta K; Falagas ME
Eur Respir J; 2007 Jun; 29(6):1127-37. PubMed ID: 17301097
[TBL] [Abstract][Full Text] [Related]
28. Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.
Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2007; 2(3):191-204. PubMed ID: 18229559
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation and symptomatic treatment of surinfectious exacerbations of COPD: preliminary study of antibiotic treatment combined with fenspiride (Pneumorel 80mg) versus placebo].
Lirsac B; Benezet O; Dansin E; Nouvet G; Stach B; Voisin C
Rev Pneumol Clin; 2000 Feb; 56(1):17-24. PubMed ID: 10740110
[TBL] [Abstract][Full Text] [Related]
30. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
31. Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.
Brusse-Keizer M; VanderValk P; van der Zanden RW; Nijdam L; van der Palen J; Hendrix R; Movig K
Int J Chron Obstruct Pulmon Dis; 2015; 10():455-61. PubMed ID: 25767383
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
33. Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment.
Wenisch C; Krause R; Széll M; Laferl H
Infection; 2006 Aug; 34(4):190-5. PubMed ID: 16896576
[TBL] [Abstract][Full Text] [Related]
34. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
35. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
[TBL] [Abstract][Full Text] [Related]
36. A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.
Schaberg T; Ballin I; Huchon G; Bassaris H; Hampel B; Reimnitz P;
J Int Med Res; 2001; 29(4):314-28. PubMed ID: 11675905
[TBL] [Abstract][Full Text] [Related]
37. Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis.
Aubier M; Aldons PM; Leak A; McKeith DD; Leroy B; Rangaraju M; Bienfait-Beuzon C
Respir Med; 2002 Nov; 96(11):862-71. PubMed ID: 12418583
[TBL] [Abstract][Full Text] [Related]
38. Relation between amoxicillin concentration in sputum of COPD patients and length of hospitalization.
Brusse-Keizer M; ten Bokum L; Movig K; van der Valk P; Kerstjens H; van der Palen J; Hendrix R
COPD; 2011 Apr; 8(2):66-70. PubMed ID: 21495834
[TBL] [Abstract][Full Text] [Related]
39. No more equivalence trials for antibiotics in exacerbations of COPD, please.
Miravitlles M; Torres A
Chest; 2004 Mar; 125(3):811-3. PubMed ID: 15006934
[No Abstract] [Full Text] [Related]
40. Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease.
Miravitlles M; García-Polo C; Domenech A; Villegas G; Conget F; de la Roza C
Lung; 2013 Oct; 191(5):523-30. PubMed ID: 23842641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
